The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Approximately 1 in 4 people with Type 2 diabetes also have hypothyroidism, a condition where the thyroid gland is underactive ...

India faces a growing crisis as childhood obesity rates rise sharply, increasing risks of diabetes and vision problems. Is CBSE's sugar board initiative enough to protect children's health?

Roche RHHBY announced today that the FDA has approved a label expansion of ophthalmology drug Susvimo (ranibizumab injection). The regulatory body approved the drug Susvimo for the treatment of ...

An analysis of a large national database shows a diagnosis of bipolar disorder or major depressive disorder is linked to an ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

Novo Nordisk NVO announced the surprise resignation of its chief executive officer (CEO), Lars Fruergaard Jørgensen. Sanofi ...

MODY 5 is a rare genetic diabetes subtype caused by HNF1B mutations or deletions, often presenting with early-onset diabetes and kidney, liver, or pancreatic abnormalities. Accurate genetic diagnosis ...

An inexpensive pill for treating HIV could become an alternative to injections for diabetic eye disease, a small study ...

The Business Research Company’s Juvenile Macular Degeneration Treatment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 27, 2025 ...